HUBBARD, Ohio, May 28 /PRNewswire-FirstCall/ -- NanoLogix, Inc. (Pink Sheets: NNLX) a nano-biotechnology company is pleased to provide the following updates:
NanoLogix personnel will showcase company technology at booth 1304 at the ASM General Meeting and Exhibition in Boston, June 1-5 2008. The ASM meeting is the world's premier event for microbiology development. Representing NanoLogix will be Dr. Sergey Gazenko and CEO Bret Barnhizer. Exhibition information can be found at http://gm.asm.org/
At the ASM meeting NanoLogix will unveil ten products for use with their BNC and BNP technology for fast microorganism detection. This step is a milestone in company development. Director and company founder Dr. Robert A. Ollar, M.Sc., Ph.D. stated: "The sale of products developed by NanoLogix scientific staff marks an important stage in the evolution of the company. The firm is now putting its technologies into actual product configurations, and offering them for sale in the international market place where they will be utilized by the Global Scientific Community."
The company is also planning a new research and development facility in northeast Ohio. This facility will enable expanded R&D work on both Biohydrogen reactor development and BioNanoChannel (BNC) and BioNanoPore (BNP) technologies.
Hilda E. Diaz has joined NanoLogix in Cincinnati as assistant to Dr.
Sergey Gazenko. Ms. Diaz holds an MS in Microbiology from Xavier University
in Colombia, a BS in Bacteriology from Catholic University, and a BA in
Business Administration. Ms. Diaz has extensive research and work
experience in the field of microbiology. She was Professor in general
microbiology, food microbiology and biotechnology at Catholic University in
Colombia, and has extensive industrial experience in bacteriological
testing. The company is pleased to have Ms. Diaz contributing to its
efforts to further both Biohydrogen and BioNa
|SOURCE NanoLogix, Inc.|
Copyright©2008 PR Newswire.
All rights reserved